Drug · DIN 02541920
DAPTOMYCIN FOR INJECTION RF
SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 25, 2026; first marketed September 25, 2026.
- Drug Identification Number (DIN)
- 02541920
- Company (DIN owner)
- Eugia Pharma Inc.Woodbridge, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Daptomycin J01XX09
- Class
- Human
- Record last updated
- September 28, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DAPTOMYCIN | 500 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 29, 2023: NOC 31758Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement Between Two Manufacturers
Other DINs named DAPTOMYCIN FOR INJECTION RF
- DIN 02518856 · Cancelled Pre Market
- DIN 02540266 · Approved